If you’re thinking about buying the latest Apple Watch Series 9 or the Apple Watch Ultra 2, there’s a twist in the plot you should be aware of. These popular wearables are about to be pulled from the shelves in the United States due to a heated patent dispute over their blood oxygen sensor technology. Apple recently announced that it will suspend sales of these devices in the US temporarily.
The root of the problem lies in a legal battle between Apple and medical tech company Masimo, which filed a lawsuit in 2021, claiming that Apple violated its patents related to light-based blood-oxygen monitoring. The US International Trade Commission (ITC) upheld the judge’s ruling in October, effectively blocking imports of Apple Watch Series 9 and Ultra 2 into the US after December 25. This has forced Apple to take proactive measures, including temporarily halting sales on Apple.com and in retail stores, starting December 21 and 24, respectively.
The situation has sparked questions about intellectual property rights, patent disputes, and the impact on consumers and tech companies. Aspiring business and tech enthusiasts might wonder about the broader implications of such disputes on innovation and product availability, especially in a highly competitive market like wearable technology……….[read more]
How do companies like Apple balance protecting their intellectual property and delivering innovative products to consumers in the face of patent disputes?
*Click on the “Full Loaf” icon to read the full article! After you read the full article, let us know your thoughts.
Share this content: